Clinical Trial

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Name: Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease — clinical trial record (NCT06725693)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the potential usefulness of 68Ga/18F-Exendin 4 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various GLP-1R-related disease patients.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-12-05.

Trial Details

NCT Number	NCT06725693
Lead Sponsor	Tianjin Medical University Collaborators: Tianjin Medical University General Hospital
Conditions	GLP1-R-related Disease, Tumor, Insulinoma, Positron Emission Tomography
Enrollment	500 participants
Start Date	2019-02-01
Primary Completion	2027-11-01 (estimated)
Study Completion	2027-11-01 (estimated)
Updated on ClinicalTrials.gov	2025-02-11